Andreas Kerschbaumer

34PUBLICATIONS
119CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsAutoimmunityRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 30, 2025
Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis.

Andreas Kerschbaumer, Marlene Steiner, Suzanne Khalili

|Mar 18, 2024
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.

Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira

|Nov 03, 2023
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story.

Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati

|Oct 27, 2023
Definition of rheumatoid arthritis flare based on SDAI and CDAI.

Victoria Konzett, Andreas Kerschbaumer, Josef S Smolen

|Sep 27, 2023
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis.

Victoria Konzett, Andreas Kerschbaumer, Josef S Smolen

Pageof 6